NEORX CORP·4

Jul 5, 1:25 PM ET

NEORX CORP 4

4 · NEORX CORP · Filed Jul 5, 2005

Insider Transaction Report

Form 4
Period: 2005-07-01
KARLIN DAVID A
Sr. VP, Clinical Devlpt & Reg
Transactions
  • Award

    Employee Stock Option

    2005-07-01$0.62/sh+250,000$155,000250,000 total
    Exercise: $0.62Exp: 2015-07-01NeoRx Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]Exercisable one-fourth beginning 7/1/2006; then in equal monthly installments of 1/48th per month beginning 8/1/2006 in accordance with the vesting schedule of the NeoRx 2004 Incentive Compensation Plan.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -